How the world's leading biopharma companies are modernizing R&D with Benchling
Thursday, December 3, 2026, – (Europe/London)
Room: Threadneedle Hub · Industry speaker
Hear how Bayer and Roche are each using Benchling to modernize R&D. Bayer shares its journey from digital R&D strategy to modality-specific implementation, using Benchling as an end-to-end platform spanning design, execution, production, and analytics, with antibody-aware data management. Roche explores how a product-centric digital architecture can simplify tech transfers and enforce collaborative workflows in enterprise CMC, where research meets GMP manufacturing.
Speakers
-
Digital Product Lead, Bayer AG -
Director Data & Digital Systems & Principal Scientist, Roche